 |
Arcturus Therapeutics Holdings
ARCT
|
1.01 |
$ 7.19 |
2.2 % |
$ 197 M |
Israel |
 |
FSD Pharma
HUGE
|
1.66 |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
MorphoSys AG
MOR
|
1.28 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.115 |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
7.09 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Coherus BioSciences
CHRS
|
3.71 |
$ 1.67 |
3.73 % |
$ 196 M |
USA |
 |
I-Mab
IMAB
|
1.12 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 |
- |
- |
$ 40.3 B |
USA |
 |
Biophytis SA
BPTS
|
15.7 |
- |
-13.47 % |
$ 169 M |
France |
 |
BioNTech SE
BNTX
|
1.15 |
$ 92.05 |
-0.1 % |
$ 22.2 B |
Germany |
 |
AstraZeneca PLC
AZN
|
2.82 |
- |
- |
$ 96.9 B |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Athira Pharma
ATHA
|
0.036 |
- |
- |
$ 269 M |
USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 |
- |
0.74 % |
$ 768 M |
Israel |
 |
Compugen Ltd.
CGEN
|
1.25 |
$ 2.68 |
-4.29 % |
$ 250 M |
Israel |
 |
Abcam plc
ABCM
|
6.8 |
- |
- |
$ 4.9 B |
Britain |
 |
Galera Therapeutics
GRTX
|
-0.0532 |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Midatech Pharma plc
MTP
|
173 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Enlivex Therapeutics Ltd.
ENLV
|
0.0227 |
$ 0.68 |
-5.69 % |
$ 31.1 M |
Israel |
 |
Esperion Therapeutics
ESPR
|
-1.86 |
$ 3.13 |
- |
$ 651 M |
USA |
 |
Eton Pharmaceuticals
ETON
|
21.4 |
$ 31.48 |
-3.41 % |
$ 847 M |
USA |
 |
Affimed N.V.
AFMD
|
2.34 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
Forte Biosciences
FBRX
|
5.5 |
$ 21.47 |
-0.56 % |
$ 278 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 |
- |
- |
- |
Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
0.759 |
- |
- |
$ 231 M |
USA |
 |
Celyad Oncology SA
CYAD
|
0.539 |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
0.824 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Generation Bio Co.
GBIO
|
0.879 |
- |
- |
$ 344 M |
USA |
 |
IMV
IMV
|
-1.04 |
- |
- |
$ 13.1 M |
Canada |
 |
Akero Therapeutics
AKRO
|
4.34 |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
0.786 |
- |
0.23 % |
$ 488 M |
USA |
 |
Grifols, S.A.
GRFS
|
0.525 |
$ 7.96 |
-0.31 % |
$ 5.41 B |
Spain |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 |
- |
- |
$ 7.46 M |
Israel |
 |
Heron Therapeutics
HRTX
|
13.8 |
$ 0.86 |
0.19 % |
$ 143 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0503 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.98 |
- |
- |
$ 384 M |
Britain |
 |
Gracell Biotechnologies
GRCL
|
1.09 |
- |
- |
$ 3.37 B |
China |
 |
Anika Therapeutics
ANIK
|
1.12 |
$ 14.58 |
-2.02 % |
$ 209 M |
USA |
 |
Advaxis
ADXS
|
0.113 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
InflaRx N.V.
IFRX
|
1.52 |
$ 2.85 |
9.2 % |
$ 192 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
1.12 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
5.13 |
- |
- |
$ 867 M |
Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.458 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
0.492 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
0.505 |
$ 3.49 |
2.5 % |
$ 5.75 M |
Israel |
 |
Aptose Biosciences
APTO
|
-0.511 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Aptinyx
APTX
|
0.248 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
3.12 |
- |
-0.23 % |
$ 916 M |
USA |